Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Pending USPTO Reexamination Certicate US "336" Patent

Pending USPTO Reexamination Certicate US "336" Patent

posted on Apr 16, 2010 01:41PM

If PTSC received a favorable approval from the USPTO on the Reexamination Certicate for US Patent "336" how does that change the way in which PTSC goes after the "infringer's", rather I guess, how does TPL handle the "infringer's"

Share
New Message
Please login to post a reply